Members

The CHERUB cooperative is led by a Scientific Steering Committee (SSC) with representatives from the key partners. The day to day management of the CHERUB Cooperative is led by the CHERUB Programme Liaison Group (PLG).The CHERUB Cooperative is supported by a Secretariat hosted by the Imperial College HIV Clinical Trial Research Management Office.

CHERUB Leadership
Sarah Fidler – Imperial College London
John Frater – Oxford University

Scientific lead and co-chair of ‘CHERUB’, (Collaborative HIV Eradication of Reservoirs: UK BRC), an NIHR-supported collaboration dedicated to finding a cure for HIV infection.

Sabine Kinloch– University College London

Clinical Scientist in Antiretroviral therapy in early HIV-1 infection, HIV-1 functional cure and eradication, Prophylactic HIV-1 vaccine. Sabine Kinloch

Julie Fox – Kings College London

HIV consultant that runs the HIV clinical trials unit and carries out studies in HIV prevention and HIV therapeutics. A part of the UK CHERUB collaboration investigating approaches to finding a cure for HIV and leads an HIV prevention programme in sub-Saharan Africa.

John Thornhill – Imperial College London

Senior Clinical Research Fellow with an interest in the role of HIV tissue reservoirs and immune dysfunction in HIV persistence. Involved in clinical HIV cure intervention studies at the HIV clinical trials centre at St. Marys Hospital

Andrew Lever – Cambridge University

Group leader for studies surrounding two major groups of viruses ; lentiviruses (retroviruses) and rotaviruses. The lentiviruses include HIV-1, HIV-2 and FIV. In all of these viruses, the focus is on virus assembly, how the virus captures its RNA genome within the cell and how it uses cellular machinery to do this.

Ravindra Gupta – Cambridge University/University College London

Research in the Gupta lab focuses on host-pathogen and drug-pathogen interactions to inform HIV treatment and curative strategies

Lucy Dorrell – Oxford University

Group leader for studies surrounding two major groups of viruses ; lentiviruses (retroviruses) and rotaviruses. The lentiviruses include HIV-1, HIV-2 and FIV. In all of these viruses, the focus is on virus assembly, how the virus captures its RNA genome within the cell and how it uses cellular machinery to do this.

CHERUB Programme Liaison Group
John Frater (Chair) – Lucy Dorrell – Jodi Meyerowitz – Matthew Pace – Oxford University
Sarah Fidler – John Thornhill – Imperial College London
Caroline Foster – Imperial College Healthcare NHS Trust
Andrew Lever – Ravindra Gupta – Mark Wills – Cambridge University
Clare Jolly – University College London
Eleni Nastouli – University College Hospital
Abdel Babiker – Kholoud Porter – MRC Clinical Trials Unit at UCL
Julie Fox – John Cason – King’s College London
CHERUB Secretariat – Imperial College London
Hanna Box
Cherry Kingsley
Modupé Oke